Literature DB >> 16037953

Imparting mineral affinity to proteins with thiol-labile disulfide linkages.

Geeti Bansal1, Jennifer E I Wright, Sufeng Zhang, Ronald F Zernicke, Hasan Uludag.   

Abstract

Chemical conjugation of bisphosphonates (BPs) to proteins is an effective means to enhance binding of proteins to mineral-containing biomaterials. BPs linked to proteins with reversible (i.e., cleavable) linkages were considered desirable over the conjugates linked with stable linkages because cleavable linkages allow protein release in free form from the mineral-containing biomaterials. To explore the feasibility of creating cleavable BP-protein conjugates, an amine- and a thiol-containing BP were conjugated to the model protein Bovine Serum Albumin (BSA) with N-succinimidyl-3-(2-pyridyldithio)propionate (SPDP), which resulted in disulfide-linked BP-BSA conjugates. Although disulfide-linked conjugates were stable under aqueous conditions, the conjugates in solution were readily cleaved in the presence of physiological concentrations (approximately 0.3 mM) of the thiol compound, cysteine. The imparted mineral affinity as a result of BP conjugation, as assessed by hydroxyapatite (HA) binding in vitro, was lost upon cleavage of the disulfide-linked BP. The conjugates bound to HA were also cleavable with cysteine, but their cleavage rate was significantly reduced as compared to the conjugates in solution. In conclusion, disulfide-linked BP conjugates were shown to be readily cleavable by the amino acid cysteine and this resulted in the loss of imparted mineral affinity of the proteins. The proposed approach will be useful for modulating in vivo delivery of proteins implanted with mineral-containing biomaterials. (c) 2005 Wiley Periodicals, Inc. J Biomed Mater Res, 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16037953     DOI: 10.1002/jbm.a.30334

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  3 in total

1.  Tuning Ligand Density To Optimize Pharmacokinetics of Targeted Nanoparticles for Dual Protection against Tumor-Induced Bone Destruction.

Authors:  Joseph Vanderburgh; Jordan L Hill; Mukesh K Gupta; Kristin A Kwakwa; Sean K Wang; Kathleen Moyer; Sean K Bedingfield; Alyssa R Merkel; Richard d'Arcy; Scott A Guelcher; Julie A Rhoades; Craig L Duvall
Journal:  ACS Nano       Date:  2020-01-08       Impact factor: 15.881

2.  Doxorubicin-poly (ethylene glycol)-alendronate self-assembled micelles for targeted therapy of bone metastatic cancer.

Authors:  Wei-liang Ye; Yi-pu Zhao; Huai-qiu Li; Ren Na; Fei Li; Qi-bing Mei; Ming-gao Zhao; Si-yuan Zhou
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

3.  Enhanced model protein adsorption of nanoparticulate hydroxyapatite thin films on silk sericin and fibroin surfaces.

Authors:  Selçuk Özcan; Muhsin Çiftçioğlu
Journal:  J Mater Sci Mater Med       Date:  2021-12-23       Impact factor: 3.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.